INSIGHTS : MEDICATIONS
10023
GLOBAL
MENTAL
HEALTH
PRACTICE
GROUPS
COUNTRIES
DISCOVER
PROMOTE
SHARE
NEWEST
A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults
Hepatitis C Virus Testing and Treatment among Persons Receiving Buprenorphine in an Office-Based Program for Opioid Use Disorders
Predictors of Discontinuation, Efficacy, and Safety of Memantine Treatment for Alzheimer’s Disease: Meta-Analysis and Meta-Regression of 18 Randomized Clinical Trials...
The Effects of Memantine on Behavioral Disturbances in Patients with Alzheimer’s Disease: A Meta-Analysis
Adverse Drug Events Affecting Medication Persistence with Rivastigmine Patch Application
Effects of Olanzapine on Resting Heart Rate in Japanese Patients with Schizophrenia
Risperidone for Children and Adolescents with Autism Spectrum Disorder: A Systematic Review
Increased Risk of Dementia in Patients with Antidepressants: A Meta-Analysis of Observational Studies
Heroin-Dependent Patient Satisfaction with Methadone as a Medication Influences Satisfaction with Basic Interventions Delivered by Staff to Implement Methadone Maintenance...
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
LATEST MONOGRAPHS
Olanzapine
Medications [ Multimedia ]
Medications [ Reviews ]
SUPPLEMENTS: UPDATED
Anxiety+Medication
DOWNLOADS
Coming Soon!!
POPULAR/NEWEST
Opioids
Medications
Addiction
Medications
Sexuality
Medications
Antisocial
Medications
Medication
Stabilizers
Depression
Medications
Medication
Primary Care
Medication
Trials-Practice
Antidepressants
Health-Illness
FEATURED RESOURCES
Health+Meds
English
Asia
Europe
Non-English
Antidepressants
United States
United Kingdom
Canada
Australia
New Zealand
Meds/Young
France
Germany
Italy
Netherlands
Spain
CATEGORIES
Articles
Abstracts
Publications
Theses
Multimedia
ARCHIVES/SELECTION
Global 2018-2000
RESEARCH CONTENTS
General
Applications
Comorbidities
MORE RESOURCES
Search
Additions
Share
<< SEE GLOBAL-PRIORITIES
- UPDATED 20/09/2018 -
SEE EDITION-PRIORITIES >>
